Metrex CaviWipes 2.0 (12/Case)

Yes, Metrex CaviWipes 2.0 offer a comprehensive, broad-spectrum efficacy against a wide range of pathogens, achieving universal effectiveness in just two minutes.

These disinfecting wipes are effective against:

• Over 40 pathogens
• All virus types (enveloped, large, and small non-enveloped)
• Bacteria and Fungi

They meet important medical compliance standards, including efficacy claims for:

• Tuberculocidal, Bactericidal, Virucidal, and Fungicidal activity.
• Effectiveness against SARS-CoV-2 (compliant with EPA List N).
• Meeting OSHA’s Bloodborne Pathogen Guidelines.

Yes, Metrex CaviWipes 2.0 are highly effective and compliant with the latest standards for viral control.

Key compliance points include:

• EPA List N Compliant: The wipes are proven effective against SARS-CoV-2.
• Emerging Viral Pathogen Claim: They qualify for the EPA’s rigorous Emerging Viral Pathogen Claim, ensuring readiness against current and future outbreaks.
• Broad-Spectrum Efficacy: These wipes are effective against all virus types (enveloped, large and small non-enveloped) and over 40 pathogens in total, achieving universal efficacy in a rapid two-minute contact time.

The Metrex CaviWipes 2.0 are packaged for high-volume use, providing a total of 1,920 disinfecting towelettes per case.

The case configuration includes:

• 12 canisters
• 160 towelettes per individual canister

Yes, Metrex CaviWipes 2.0 are formulated for broad-spectrum efficacy and are proven effective against over 40 different pathogens.

Key aspects of their comprehensive coverage include:

• Pathogen Types: Effective against all virus types (enveloped, large and small non-enveloped viruses), bacteria, and fungi. They are also tuberculocidal.
• Rapid Action: They achieve universal contact time efficacy against bacteria, fungi, and most pathogens in just two minutes.
• Emerging Threat Ready: CaviWipes 2.0 qualifies for the EPA’s rigorous Emerging Viral Pathogen Claim and is compliant with EPA List N, confirming efficacy against SARS-CoV-2.
• OSHA Compliant: They meet OSHA’s Bloodborne Pathogen Guidelines as a 1-Step Germicide, making them suitable for high-level disinfection in demanding clinical environments.

Yes, Metrex CaviWipes 2.0 are designed for convenient and efficient cleaning as a 1-Step Germicide.

This means they clean and disinfect simultaneously, eliminating the need for a separate pre-cleaning step on most hard, non-porous surfaces.

Key benefits of this one-step formula include:

• Rapid Efficacy: A universal contact time of just two minutes is required to be effective against bacteria, fungi, and over 40 pathogens.
• Broad Coverage: The wipes offer Tuberculocidal, Bactericidal, Virucidal, and Fungicidal claims.
• High Compliance: They meet OSHA’s Bloodborne Pathogen Guidelines and are compliant with EPA List N, proving efficacy against SARS-CoV-2. They also qualify for the EPA’s rigorous Emerging Viral Pathogen Claim.

Yes, Metrex CaviWipes 2.0 provide powerful, broad-spectrum efficacy. They are proven effective against over 40 pathogens, encompassing all virus types (enveloped, large, and small non-enveloped), bacteria, and fungi. This rapid action is achieved with a universal contact time of just two minutes on hard, non-porous surfaces.

Key aspects of the efficacy and compliance include:

• Comprehensive Claims: Meets tuberculocidal, bactericidal, virucidal, and fungicidal claims.
• Viral Efficacy: Proven effective against SARS-CoV-2 (COVID-19) and compliant with EPA List N.
• Future Readiness: Qualifies for the EPA’s rigorous Emerging Viral Pathogen Claim, supporting proactive infection control.
• Usage: Meets OSHA’s Bloodborne Pathogen Guidelines as a 1-Step Germicide for cleaning and disinfection.

Metrex CaviWipes 2.0 are high-performance, one-step disinfecting towelettes designed for demanding environments where high-level surface disinfection is required. They are ideal for use in:

• Hospitals and Clinics
• Schools
• Care Centers

These wipes are formulated to be compatible and effective on most hard, non-porous surfaces, fulfilling both cleaning and disinfection requirements in a single step.

CaviWipes 2.0 are effective against Mycobacterium tuberculosis (TB).

No, CaviWipes 2.0 are designed for use on hard, non-porous surfaces only.

The Metrex CaviWipes 2.0 are sold in a bulk case configuration, providing a total of 1,920 towelettes.

Here is the breakdown of the contents per case:

• Canisters: 12
• Wipes per canister: 160